Neuroretinitis and encephalopathy due to Bartonella henselae infection.
McGrath
N
N
Wallis
W
W
Ellis-Pegler
R
R
Morris
A J
AJ
Taylor
W
W
D000328:Adult; D000818:Animals; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000032:analysis; D018416:Bartonella henselae / Q000276:immunology / Q000302:isolation & purification*; D002372:Cat-Scratch Disease / Q000150:complications* / Q000188:drug therapy; D002415:Cats; D002443:Ceftriaxone / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D004660:Encephalitis / Q000188:drug therapy / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009902:Optic Neuritis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D012173:Retinitis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D012293:Rifampin / Q000627:therapeutic use
D000904:Antibiotics, Antitubercular; D000907:Antibodies, Bacterial; D002511:Cephalosporins; D002443:Ceftriaxone; D012293:Rifampin